Overview
Erica Travaglino practices practicing medicine in Pavia, Italy.
Ms. Travaglino is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Erythroid Leukemia (AEL), Chronic Myelomonocytic Leukemia (CMML), and Anemia.
She is actively involved in clinical research, co-authoring 34 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Erica Travaglino
Is Erica Travaglino a top-rated expert for Myelodysplastic Syndrome (MDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Erica Travaglino is classified as an Distinguished expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Erica Travaglino participate in research or clinical trials?
Yes. Erica Travaglino has published 34 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Erica Travaglino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myelodysplastic Syndrome (MDS)Ms. Travaglino isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Erythroid Leukemia (AEL)Ms. Travaglino isAdvanced. Learn about Acute Erythroid Leukemia (AEL).
- AnemiaMs. Travaglino isAdvanced. Learn about Anemia.
- Chronic Myelomonocytic Leukemia (CMML)Ms. Travaglino isAdvanced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Travaglino isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Castleman DiseaseMs. Travaglino isExperienced. Learn about Castleman Disease.
- Essential ThrombocythemiaMs. Travaglino isExperienced. Learn about Essential Thrombocythemia.
- LeukemiaMs. Travaglino isExperienced. Learn about Leukemia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Sideroblastic AnemiaMs. Travaglino isExperienced. Learn about Sideroblastic Anemia.